GMP Contracting, Inc.

​​"FDA strongly recommends that your management immediately undertake a comprehensive assessment of your operations, including facility design, procedures, personnel, processes, materials and systems. In particular, this review should assess your aseptic processing operations. A third party consultant with relevant sterile drug manufacturing expertise could be useful in conducting this comprehensive evaluation."

Standard statement used in FDA Warning Letters issued to Compounding Pharmacies.

Contact Us

Matt Bestercy      (631) 838-9083


Stay Connected

CoMPOUNDING pharmacies

  • Comprehensive Operation Assessments
  • Corrective Action Plans
  • ​Establishment of a Quality Management System (QMS)
  • Interim Controls
  • Mock FDA audits
  • 503B cGMP Compliance
  • 503A Aseptic Practices Compliance
Technical Services for Manufacturers of Pharmaceuticals and B​iologics